Med-El US Standard Pro and Micro Pro Rechargeable Batteries Now Available for Sonnet 2 and Sonnet 3 Users
The new battery options offer up to 23 hours of hearing on a single charge and are compatible with Med-El implants dating back to 1994.
The new battery options offer up to 23 hours of hearing on a single charge and are compatible with Med-El implants dating back to 1994.
Spangler will succeed founding ACI Alliance executive director Donna Sorkin, officially assuming the role in mid-June.
Phonak University 2026 helped prepare students for audiology careers with hands-on experience in hearing aids, cochlear implants, and job interviewing skills.
A deep transfer learning AI model predicted spoken language outcomes in children one to three years after cochlear implantation with 92% accuracy.
Read MoreRegistration is open for the American Cochlear Implant Alliance CI2026 Chicago Conference on Cochlear Implants.
Read MoreThe FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
Read MoreThe Niparko Memorial Lecturer for CI2026 Chicago will present on “Tonotopic Coding in Cochlear Implantation.”
Read MoreA University of Oklahoma researcher is studying how children with cochlear implants use sensory feedback from their mouths and tongues to develop speech, exploring whether enhancing oral motor training could improve language outcomes.
Read MoreEnvoy Medical has received FDA approval to expand its pivotal clinical trial for the fully implanted Acclaim cochlear implant, accelerating its path to commercialization.
Read MoreA cochlear implant (CI) program in South Carolina has demonstrated how strategic workflow design, data-driven efficiency measures, and team-based care can dramatically expand access, improve patient satisfaction, and sustain rapid program growth in an underserved region.
Read MoreACI Alliance has begun a search for its next executive director as founding leader Donna Sorkin prepares to step down.
Read MoreEnvoy Medical has secured three new patents in the U.S., Australia, and Hong Kong for fully implantable cochlear implant solutions.
Read MoreA recent study of outcomes in infants and young deaf children with cochlear implants suggests that socioeconomic status plays a major role in whether spoken language becomes their primary communication mode.
Read MoreCochlear’s newly FDA approved Nucleus Nexa System is reportedly the world’s first smart cochlear implant and features upgradeable firmware.
Read MoreACI Alliance is accepting abstract submissions for its upcoming clinical research conference, CI2026 Chicago: Conference on Cochlear Implants in Children and Adults.
Read MoreDualSync is a bimodal streaming solution designed to enable seamless audio streaming from Apple devices to compatible hearing aids and cochlear implants.
Read MoreDespite significant advances in cochlear implant technology and expanded candidacy criteria, access to these life-changing devices remains limited, prompting professionals to find new ways to close the gap in care.
Read MoreThree students were recognized for research on auditory development, music perception, and cochlear implantation in unique populations.
Read More